Literature DB >> 23261390

P-glycoprotein is fully active after multiple tryptophan substitutions.

Douglas J Swartz1, Joachim Weber, Ina L Urbatsch.   

Abstract

P-glycoprotein (Pgp) is an important contributor to multidrug resistance of cancer. Pgp contains eleven native tryptophans (Trps) that are highly conserved among orthologs. We replaced each Trp by a conservative substitution to determine which Trps are important for function. Individual Trp mutants W44R, W208Y, W132Y, W704Y and W851Y, situated at the membrane surface, revealed significantly reduced Pgp induced drug resistance against one or more fungicides and/or reduced mating efficiencies in Saccharomyces cerevisiae. W158F and W799F, located in the intracellular coupling helices, abolished mating but retained resistance against most drugs. In contrast, W228F and W311Y, located within the membrane, W694L, at the cytoplasmic membrane interface, and W1104Y in NBD2 retained high levels of drug resistance and mating efficiencies similar to wild-type Pgp. Those were combined into pair (W228F/W311Y and W694L/W1104Y) and quadruple (W228F/W311Y/W694L/W1104Y) mutants that were fully active in yeast, and could be purified to homogeneity. Purified pair and quad mutants exhibited drug-stimulated ATPase activity with binding affinities very similar to wild-type Pgp. The combined mutations reduced Trp fluorescence by 35%, but drug induced fluorescence quenching was unchanged from wild-type Pgp suggesting that several membrane-bound Trps are sensitive to drug binding. Overall, we conclude that Trps at the membrane surface are critical for maintaining the integrity of the drug binding sites, while Trps in the coupling helices are important for proper interdomain communication. We also demonstrate that functional single Trp mutants can be combined to form a fully active Pgp that maintains drug polyspecificity, while significantly reducing intrinsic fluorescence.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23261390      PMCID: PMC3602414          DOI: 10.1016/j.bbamem.2012.12.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  60 in total

Review 1.  The controversial role of ABC transporters in clinical oncology.

Authors:  Akina Tamaki; Caterina Ierano; Gergely Szakacs; Robert W Robey; Susan E Bates
Journal:  Essays Biochem       Date:  2011-09-07       Impact factor: 8.000

Review 2.  Fluorescence techniques for studying protein structure.

Authors:  M R Eftink
Journal:  Methods Biochem Anal       Date:  1991

Review 3.  The membrane-water interface region of membrane proteins: structural bias and the anti-snorkeling effect.

Authors:  Jie Liang; Larisa Adamian; Ronald Jackups
Journal:  Trends Biochem Sci       Date:  2005-07       Impact factor: 13.807

Review 4.  The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research.

Authors:  Michael M Gottesman; Victor Ling
Journal:  FEBS Lett       Date:  2005-12-28       Impact factor: 4.124

5.  Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein.

Authors:  A B Shapiro; V Ling
Journal:  Eur J Biochem       Date:  1997-11-15

6.  Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.

Authors:  C P Leith; K J Kopecky; I M Chen; L Eijdems; M L Slovak; T S McConnell; D R Head; J Weick; M R Grever; F R Appelbaum; C L Willman
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

7.  Both P-glycoprotein nucleotide-binding sites are catalytically active.

Authors:  I L Urbatsch; B Sankaran; S Bhagat; A E Senior
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

8.  Probing of the rates of alternating access in LacY with Trp fluorescence.

Authors:  Irina Smirnova; Vladimir Kasho; Junichi Sugihara; H Ronald Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-03       Impact factor: 11.205

Review 9.  ABC transporters: a riddle wrapped in a mystery inside an enigma.

Authors:  Peter M Jones; Megan L O'Mara; Anthony M George
Journal:  Trends Biochem Sci       Date:  2009-09-11       Impact factor: 13.807

10.  Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  J Biol Chem       Date:  2003-08-07       Impact factor: 5.157

View more
  9 in total

1.  2,4,6-Tribromophenol Exposure Decreases P-glycoprotein Transport at the Blood-Brain Barrier.

Authors:  Andrew W Trexler; Gabriel A Knudsen; Sascha C T Nicklisch; Linda S Birnbaum; Ronald E Cannon
Journal:  Toxicol Sci       Date:  2019-07-31       Impact factor: 4.849

Review 2.  Disruption of small molecule transporter systems by Transporter-Interfering Chemicals (TICs).

Authors:  Sascha C T Nicklisch; Amro Hamdoun
Journal:  FEBS Lett       Date:  2020-12-09       Impact factor: 4.124

3.  Insights Into the Molecular Mechanism of Triptan Transport by P-glycoprotein.

Authors:  Laura A Wilt; Diana Nguyen; Arthur G Roberts
Journal:  J Pharm Sci       Date:  2017-03-07       Impact factor: 3.534

4.  A Conformationally Gated Model of Methadone and Loperamide Transport by P-Glycoprotein.

Authors:  Morgan E Gibbs; Laura A Wilt; Kaitlyn V Ledwitch; Arthur G Roberts
Journal:  J Pharm Sci       Date:  2018-02-28       Impact factor: 3.534

5.  Structure-based alteration of tryptophan residues of the multidrug transporter CmABCB1 to assess substrate binding using fluorescence spectroscopy.

Authors:  Yoshiki Inoue; Tomohiro Yamaguchi; Tetsuo Otsuka; Yuto Utsunomiya; Dongqing Pan; Haruo Ogawa; Hiroaki Kato
Journal:  Protein Sci       Date:  2022-06       Impact factor: 6.993

6.  Global marine pollutants inhibit P-glycoprotein: Environmental levels, inhibitory effects, and cocrystal structure.

Authors:  Sascha C T Nicklisch; Steven D Rees; Aaron P McGrath; Tufan Gökirmak; Lindsay T Bonito; Lydia M Vermeer; Cristina Cregger; Greg Loewen; Stuart Sandin; Geoffrey Chang; Amro Hamdoun
Journal:  Sci Adv       Date:  2016-04-15       Impact factor: 14.136

7.  Pore-exposed tyrosine residues of P-glycoprotein are important hydrogen-bonding partners for drugs.

Authors:  Yaprak Dönmez Cakil; Narakorn Khunweeraphong; Zahida Parveen; Diethart Schmid; Matthias Artaker; Gerhard F Ecker; Harald H Sitte; Oliver Pusch; Thomas Stockner; Peter Chiba
Journal:  Mol Pharmacol       Date:  2013-12-23       Impact factor: 4.436

8.  Directed evolution of P-glycoprotein cysteines reveals site-specific, non-conservative substitutions that preserve multidrug resistance.

Authors:  Douglas J Swartz; Leo Mok; Sri K Botta; Anukriti Singh; Guillermo A Altenberg; Ina L Urbatsch
Journal:  Biosci Rep       Date:  2014-06-25       Impact factor: 3.840

9.  Replacing the eleven native tryptophans by directed evolution produces an active P-glycoprotein with site-specific, non-conservative substitutions.

Authors:  Douglas J Swartz; Anukriti Singh; Narong Sok; Joshua N Thomas; Joachim Weber; Ina L Urbatsch
Journal:  Sci Rep       Date:  2020-02-21       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.